- Home
- LPCN vs SMSI Comparison
LPCN vs SMSI Comparison
Compare LPCN & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- SMSI
- Stock Information
- Founded
- LPCN 1997
- SMSI 1982
- Country
- LPCN United States
- SMSI United States
- Employees
- LPCN N/A
- SMSI N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- SMSI Computer Software: Prepackaged Software
- Sector
- LPCN Health Care
- SMSI Technology
- Exchange
- LPCN Nasdaq
- SMSI Nasdaq
- Market Cap
- LPCN 18.2M
- SMSI 15.3M
- IPO Year
- LPCN N/A
- SMSI 1995
- Fundamental
- Price
- LPCN $2.60
- SMSI $0.66
- Analyst Decision
- LPCN Strong Buy
- SMSI Strong Buy
- Analyst Count
- LPCN 1
- SMSI 1
- Target Price
- LPCN $8.00
- SMSI $5.00
- AVG Volume (30 Days)
- LPCN 59.9K
- SMSI 1.3M
- Earning Date
- LPCN 11-07-2025
- SMSI 11-05-2025
- Dividend Yield
- LPCN N/A
- SMSI N/A
- EPS Growth
- LPCN N/A
- SMSI N/A
- EPS
- LPCN N/A
- SMSI N/A
- Revenue
- LPCN $4,208,119.00
- SMSI $18,658,000.00
- Revenue This Year
- LPCN N/A
- SMSI N/A
- Revenue Next Year
- LPCN N/A
- SMSI $59.48
- P/E Ratio
- LPCN N/A
- SMSI N/A
- Revenue Growth
- LPCN N/A
- SMSI N/A
- 52 Week Low
- LPCN $2.57
- SMSI $0.60
- 52 Week High
- LPCN $6.17
- SMSI $1.95
- Technical
- Relative Strength Index (RSI)
- LPCN 32.60
- SMSI 38.37
- Support Level
- LPCN $2.75
- SMSI $0.69
- Resistance Level
- LPCN $2.92
- SMSI $0.74
- Average True Range (ATR)
- LPCN 0.14
- SMSI 0.05
- MACD
- LPCN -0.05
- SMSI -0.01
- Stochastic Oscillator
- LPCN 4.69
- SMSI 4.86
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.